| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.09 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |